SCHEMBL22006393

SCHEMBL22006393

c1ccc(-c2cccc(-c3nc(-c4ccccc4)nc4c3oc3c(-c5cccc(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)c5)cccc34)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PRKDC P78527 7/20 0.35
PTGER4 P35408 1/20 0.33
PIM1 P11309 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
PIM3 Q86V86 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
TSHR P16473 1/20 0.31
NPY5R Q15761 1/20 0.31
AVPR1A P37288 1/20 0.30
TSPO P30536 1/20 0.30
PIK3CA P42336 2/20 0.30
PIK3CD O00329 1/20 0.30
PIK3CB P42338 1/20 0.30
PIK3CG P48736 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22006562 0.98 ATM (0.35) KDM4EATML3MBTL1PRKDCPTGER4
SCHEMBL23789585 0.98 KDM4E (0.35) KDM4EATML3MBTL1PRKDCPTGER4
SCHEMBL22006802 0.97 KDM4E (0.36) KDM4EATML3MBTL1PRKDCPTGER4
SCHEMBL23380769 0.95 KDM4E (0.36) KDM4EATML3MBTL1PRKDCPTGER4
SCHEMBL22007492 0.95 KDM4E (0.36) KDM4EATML3MBTL1PRKDCPTGER4
SCHEMBL22006323 0.94 PDE10A (0.33) KDM4EATML3MBTL1PRKDCPTGER4
SCHEMBL22006609 0.94 KDM4E (0.35) KDM4EATML3MBTL1PRKDCTSHR
SCHEMBL20024193 0.93 KDM4E (0.33) KDM4EATML3MBTL1PRKDCPTGER4
SCHEMBL22006314 0.93 PRKDC (0.36) KDM4EATML3MBTL1PRKDCTSHR
SCHEMBL22006312 0.93 PRKDC (0.36) KDM4EATML3MBTL1PRKDCTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200161564-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200161564-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OXER1, OR10J3, OCIAD1 KDM4E 4066/4885ATM 3422/4885L3MBTL1 2156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.